CSI in the News

09/26/2022 – 4:00 PM
Notice of Phishing Incident

04/20/2022 – 04:05 PM
Fulgent Genetics Agrees to Acquire Inform Diagnostics

08/09/2021 – 04:05 PM
Fulgent Genetics Announces Acquisition of CSI Laboratories

08/09/2021 – 04:05 PM
CSI Laboratories Announces Expanded Tech-Only FISH Menu

08/21/2019 – 08:00 AM
CSI Laboratories Announces New Line of Capital

07/09/2019 – 07:30 AM
CSI Laboratories Announces Equity Stake Acquisition by Synergy Capital Investments

03/18/2019 – 07:30 AM
CSI Laboratories Begins Offering VENTANA PD-L1 (SP142) Assay as Companion Diagnostic Test for Triple Negative Breast Cancer as a Result of FDA Approval for TENCENTRIQ® (atezolizumab)

02/12/2019 – 08:30 AM
CSI Laboratories Announces Opening of New Laboratory in Jupiter, Fla.

12/05/2018 – 10:30 AM
CSI Laboratories Advances Precision in Cancer Diagnostics by Partnering with Dr. Maher Albitar of Genomics Testing Cooperative (GTC)

02/20/2018 – 05:00 AM
CSI Laboratories Announces Construction of New Cancer Diagnostics Laboratory in Florida

03/14/2017 – 09:00 AM
CSI Laboratories Partnership with Avalon Healthcare Solutions to Benefit Patients in South Carolina

07/08/2016 – 09:56 PM
CSI Laboratories Now Offering PD-L1 Expression Assay Used in Conjunction with Multiple Immunotherapies

05/28/2015 – 04:45 AM
CSI Laboratories Holds Ribbon Cutting Ceremony for New Molecular Laboratory

12/01/2014 – 04:09 PM
CSI Laboratories Breaks Ground on Multimillion-Dollar Molecular Laboratory